Methods of diagnosis and treatment targeting of clinically intractable malignant tumors

摘要

The present disclosure is based on the endogenous human stem cell-associated retrovirus (SCAR) genome and proteomic signature, gene expression, and activation based on disease states (eg, cancer treatment efficacy status, cancer treatment progression, cancer prognosis, Covers methodologies or techniques for generating predictors of cancer diagnosis, treatment failure, relapse, recurrence, etc. The present disclosure is also directed to methods of targeting, designing and using treatment for clinically refractory malignancies. [Selection] Figure 1A